GRANDALIANO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 5.597
EU - Europa 5.093
AS - Asia 2.869
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
AF - Africa 5
Totale 13.633
Nazione #
US - Stati Uniti d'America 5.566
CN - Cina 1.845
IE - Irlanda 1.709
UA - Ucraina 1.287
SE - Svezia 725
IT - Italia 324
HK - Hong Kong 312
FI - Finlandia 302
DE - Germania 285
SG - Singapore 247
IN - India 242
FR - Francia 212
TR - Turchia 158
GB - Regno Unito 116
CZ - Repubblica Ceca 40
BR - Brasile 36
BE - Belgio 35
CA - Canada 28
KR - Corea 21
RU - Federazione Russa 20
EU - Europa 14
PK - Pakistan 13
NL - Olanda 12
ES - Italia 10
AU - Australia 7
CL - Cile 5
JP - Giappone 5
ID - Indonesia 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IQ - Iraq 3
MX - Messico 3
RO - Romania 3
SA - Arabia Saudita 3
EC - Ecuador 2
IR - Iran 2
MY - Malesia 2
PL - Polonia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
VE - Venezuela 1
Totale 13.633
Città #
Dublin 1.709
Chandler 1.022
Jacksonville 913
Dearborn 532
Nyköping 486
Nanjing 463
Hong Kong 311
Wilmington 215
Beijing 213
Ashburn 207
Santa Clara 199
Nanchang 191
Princeton 189
San Mateo 181
Munich 162
Singapore 140
Helsinki 135
New York 128
Shenyang 121
Boardman 111
Ann Arbor 96
Hebei 83
Des Moines 76
Jiaxing 74
Changsha 65
Kunming 65
Tianjin 61
Jinan 48
Hangzhou 41
Shanghai 41
Pune 40
Woodbridge 40
Ningbo 37
Brno 35
Guangzhou 35
Foggia 33
Zhengzhou 33
Brussels 32
Taizhou 30
Los Angeles 26
Seattle 26
Hilden 24
Lanzhou 21
Auburn Hills 18
Bari 16
Wuhan 16
Augusta 15
Orange 15
Toronto 15
Changchun 14
Rome 14
Lahore 13
Norwalk 12
Falls Church 11
Fuzhou 10
Leawood 10
Washington 10
Saint Petersburg 9
Shenzhen 9
London 8
Hefei 7
Milan 7
San Francisco 7
Bologna 6
Haikou 6
Redwood City 6
Jinhua 5
Padova 5
Paris 5
São Paulo 5
Bisceglie 4
Borås 4
Clifton 4
Dongyang 4
Kolkata 4
Murcia 4
Nuremberg 4
Olomouc 4
Ottawa 4
Palese 4
Rockville 4
Stevenage 4
Xuzhou 4
Amsterdam 3
Avigliano 3
Baghdad 3
El Segundo 3
Florence 3
Genova 3
Jakarta 3
Kocaeli 3
Melbourne 3
Mountain View 3
Noicattaro 3
Palermo 3
Philadelphia 3
Redmond 3
Rui'an 3
Shaoxing 3
Trieste 3
Totale 9.067
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 205
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 189
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 180
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 135
La riduzione dei livelli sierici di BAFF e APRIL si associa alla negativizzazione degli anticorpi anti-recettore della fosfolipasi A2 (PLA2R) nei pazienti affetti da glomerulonefrite membranosa idiopatica (iMN) 124
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 118
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 117
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 115
Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? 114
Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy. 112
Sirolimus interferes with iron homeostasis in renal transplant recipients 110
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 108
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 106
PROSTATE CANCER IS CHARACTERIZED BY A DYSREGULATION OF THE IMMUNE RESPONSE 106
ADAMTS13 MUTATIONS AND POLYMORPHISMS IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA. 104
[Cardiovascular risk in polycystic kidney disease] 104
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 104
“Espressione renale della proteina chemotattica per i monociti (MCP-1) e del fattore di crescita epidermico (EGF) in bambini affetti da stenosi del giunto pielo-ureterale (SGPU).” 103
“Urinary epidermal growth factor (EGF) concentration in children affected by severe obstructive and reflux uropathy”. 102
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 102
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 100
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 100
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 100
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. 98
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 95
Epidemal growth factor and monocyte chemotactic protein-1 renal expression and urinary levels in pediatric ureteropelvic junction obstruction 95
Renal cortical complement C3 gene expression in IgA nephropathy 93
Proteomic profile of plasma proteins eluted from Coupled Plasma Filtration-Adsorption (CPFA) sorbent resin cartridges in a swine model of sepsis 93
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells. 92
Creazione di un database multimediale per la gestione della telepatologia statica e della telemorfometria nella immunopatologia renale 92
“Epidermal growth factor (EGF) and monocyte chemotactic peptide-1 (MCP-1) renal expression in children affected by ureteropelvic junction obstruction” 92
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. 92
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 92
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients 91
High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. 91
La Fetuina A è ridotta nel siero e nelle urine dei pazienti affetti da nefro-urolitiasi ricorrente 90
Espressione renale e livelli urinari di fattore di crescita epidermico ed proteina chemotattica dei monociti-1 in bambini con stenosi del giunto pielo-ureterale 89
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. 89
Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. 88
Clinical and therapeutic aspects of diabetic nephropathy 88
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 87
Altered urinary excretion of aquaporin 2 in IgA nephropathy. 87
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 86
Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients. 86
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 86
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression 86
INCREASE OF PROLIFERATING RENAL PROGENITOR CELLS IN ACUTE TUBULAR NECROSIS UNDERLYING DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANTATION 86
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 86
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 86
Acute renal failure in critically ill patients. 85
Cardiovascular risk and renal transplantation 85
Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase. 85
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant. 85
Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction 84
Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. 84
Placental imbalance of vasoactive factors does not affect pregnancy outcome in patients treated with cyclosporine A after transplant 83
Thrombin: a novel renal growth factor. 82
Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. 82
Children with obstructive uropathy showed renal overexpression of plasminogen activator inhibitor-1 unrelated to renal expression of angiotensinogen 81
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 81
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation 81
mTOR inhibitors effects on regulatory T cells and on dendritic cells 81
Rapamycin treatment for benign multicystic peritoneal mesothelioma: A rare disease with a difficult management 81
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 80
Acute kidney injury in the elderly population. 80
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 79
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 78
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) 77
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 76
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 76
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 76
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 76
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics 76
Angiotensin IV and renal diseases. 75
Cytokines and bioincompatibility 74
Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. 74
Trapianto di rene doppio. Analisi retrospettiva dei dati relativi alla popolazione dei pazienti portatori di trapianto renale doppio in ambito AIRT 74
Actions of platelet-derived growth factor isoforms in mesangial cells. 74
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 74
“Monocyte chemotatic protein-1 and epidermal growth factor (EGF) expression and secretion in xanthogranulomatous pyelonephritis 73
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 73
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN DULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION. 73
Allograft nephrectomy: what is the best surgical technique? 73
Treatment with rituximab in idiopathic membranous nephropathy 73
Clinical relevance of citokine production in hemodialysis. 72
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 72
Inflammation and carnitine in hemodialysis patients. 72
Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction. 71
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD. 70
Management and prevention of post-transplant malignancies in kidney transplant recipients 70
Management of Side Effects of Sirolimus Therapy. 69
The role of hyperparathyroidism, erythropoietin therapy, and CMV infections in the failure of arteriovenous fistula in hemodialysis. 69
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway 69
Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral blood mononuclear cells. 68
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 68
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 68
The role of tubular cells in the progression of renal damage: guilty or innocent? 67
Renal injury after low-or iso-osmolar contrast agent exposure:an in vitro study 67
Dialysis-related systemic microinflammation is associated with specific genomic patterns. 66
Recidive della nefropatia di base e nefropatie “de novo” in pazienti portatori di trapianto renale 66
Totale 8.942
Categoria #
all - tutte 70.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020595 0 0 0 0 0 0 0 47 247 42 236 23
2020/20211.475 199 8 191 15 189 100 217 61 210 270 12 3
2021/2022968 171 3 39 15 63 16 17 76 125 114 35 294
2022/20234.148 376 200 244 247 221 353 37 297 1.985 18 66 104
2023/2024813 92 22 37 32 53 280 68 60 4 11 13 141
2024/20251.334 170 15 113 95 90 565 204 82 0 0 0 0
Totale 13.899